On (b)(6) 2014, subject underwent intervention of a 40 mm, (b)(4) stenotic lesion in the left proximal sfa.The lesion was predilated with a 4 mm pta balloon at 10 atm resulting in a (b)(4) residual stenosis.The subject was then randomized to a bare balloon.The study balloon was inflated to 10 atm for 3 minutes with a 0% residual stenosis.No complications occurred during the procedure and the subject was discharged per plan on (b)(6) 2014.The subject completed all required study follow-up visits through 24 months, with the last visit occurring on (b)(6) 2016.On (b)(6) 2015, the subject received a diagnosis of suspected pancreatic cancer.Surgery was refused.Biliary stent was implanted ( date unknown).On (b)(6) 2015, it was noted that the target lesion had restenosis (left proximal sfa).On (b)(6) 2016 the subject underwent a revascularization procedure with pta to treat the restenosis of the target lesion.The subject was hospitalized with cholangiosepsis on (b)(6) 2016 and a secondary biliary stent was implanted as the first was occluded.On (b)(6) 2017 the subject was hospitalized for complaint of epigastric pain and significant tumor progression was noted.On (b)(6) 2017 the subject was hospitalized with suspected peritoneal carcinoma.On (b)(6) 2017 the clinical site became aware that the subject had died on (b)(6) 2017.Per the site, the cause of death is known pancreatic carcinoma (advanced); paralytic ileus and metabolic derailment.The physician does not believe that the device malfunction is the contributory cause for the death.
|